This invention relates to the treatment of pre-term neonates with paraoxonase 3 (PON3) or serum amyloid A like protein 3 (SAA3) to reduce or prevent the morbidity and mortality associated with prematurity.
申请公布号
WO2011048387(A3)
申请公布日期
2011.07.21
申请号
WO2010GB01965
申请日期
2010.10.22
申请人
CAMBRIDGE ENTERPRISE LIMITED;SMITH, GORDON;CHARNOCK-JONES, DAVID STEPHEN
